
Listen in to learn the latest on ART switch strategies for people living with virologically suppressed HIV. Hear from experts Chloe Orkin, MBChB, FRCP, MD, and Peter J. Ruane, MD, as they review how the recent approvals fit in the treatment landscape of 2-drug, single-tablet regimens. Stream on the go or follow along with our expert-curated slides. Topics covered include: Guideline recommendations on ART switch in the setting of virologic suppression Phase III clinical trial data supporting ART switch Individual considerations for ART switch Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Presenters: Chloe Orkin, MBChB, FRCP, MD Professor of Infection and Inequities Dean for Healthcare Transformation Faculty of Medicine and Dentistry Queen Mary University of London London, United Kingdom of Great Britain and Northern Ireland Honorary Consultant Physician Barts Health NHS Trust London, United Kingdom Peter J. Ruane, MD President Ruane Clinical Research Los Angeles, California Link to program page: https://bit.ly/3PkPoP4 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

DeLIVERing Prevention Podcast: Optimizing Uptake of Hepatitis A and B Vaccination

Advances in ART Podcast: Putting New Data on Emerging Options in Context

My Take on Hepatitis B Challenges in the African Immigrant Community

What's New? Simplifying the Complex, Exploring New Approaches in HIV Care for Treatment-Experienced People
Free AI-powered recaps of Decera Clinical Education Infectious Disease Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.